ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-RFXANK Antibody [OTI3E7] - BSA and Azide free (A322784)

Mouse monoclonal [OTI3E7] antibody to RFXANK for Flow Cytometry, IF, IHC and WB.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 6-9 business days.
Name
Anti-RFXANK Antibody [OTI3E7] - BSA and Azide free
Description
Mouse monoclonal [OTI3E7] antibody to RFXANK.
Applications
Flow Cytometry, IF, IHC, WB
Dilutions
WB: 1:2,000, IHC: 1:150, IF: 1:100, Flow Cytometry: 1:100
Reactivity
Human, Mouse, Rat
Immunogen
Recombinant full-length human RFXANK (NP_604389), expressed in and purified from HEK293T cells.
Host
Mouse
Clonality
Monoclonal
Clone ID
OTI3E7
Isotype
IgG2b
Conjugate

Unconjugated

Purification
Protein A/G affinity chromatography.
Concentration
Reconstitution dependent.
Predicted MW
25.4 kDa
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl distilled water.
Formulation
Lyophilized from Phosphate Buffered Saline, pH 7.3, with 8% Trehalose.
Storage
Shipped at 4°C. Store at -20°C. Avoid freeze/thaw cycles.
General Notes
To guarantee optimal conjugation, we recommend performing another round of desalting for all carrier-free antibodies.
Synonyms
ANKRA1, Ankyrin repeat family A protein 1, DNA-binding protein RFXANK, Regulatory factor X subunit B, Regulatory factor X-associated ankyrin-containing protein, RFX-B, RFXB
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-RFXANK Antibody [OTI3E7] - BSA and Azide free (A322784)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-RFXANK Antibody [OTI3E7] - BSA and Azide free (A322784)

Proteins predicted to interact with RFXANK

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.8% Relevancy Score
96.4% Relevancy Score
95.4% Relevancy Score
90.5% Relevancy Score
86.4% Relevancy Score
82% Relevancy Score
80.1% Relevancy Score
75.5% Relevancy Score